Recently, mutations in the melatonin receptor 1A (MTNR1A) have been identified as a genetic cause of idiopathic osteoporosis (IOP) [84], providing further evidence for the repurposing of melatonin as a potential therapy for OP. This evidence concerns the gene MTNR1A and idiopathic juvenile osteoporosis.